{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:00:28Z","timestamp":1781661628748,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s10038-020-00849-y","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T20:02:36Z","timestamp":1602532956000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database"],"prefix":"10.1038","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-8494","authenticated-orcid":false,"given":"Maiko","family":"Okano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nomizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunoshin","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nagatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Katagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"849_CR1","unstructured":"Breast Cancer Risk and Prevention. https:\/\/www.cancer.org\/cancer\/breast-cancer\/risk-and-prevention.html. 2020."},{"key":"849_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamasurg.2017.0552","volume":"152","author":"OM Valencia","year":"2017","unstructured":"Valencia OM, Samuel SE, Viscusi RK, Riall TS, Neumayer LA, Aziz H. The role of genetic testing in patients with breast cancer: a review. JAMA Surg. 2017;152:589\u201394.","journal-title":"JAMA Surg"},{"key":"849_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11154-007-9038-0","volume":"8","author":"AR Bradbury","year":"2007","unstructured":"Bradbury AR, Olopade OI. Genetic susceptibility to breast cancer. Rev Endocr Metab Disord. 2007;8:255\u201367.","journal-title":"Rev Endocr Metab Disord"},{"key":"849_CR4","unstructured":"SEER Stat Fact Sheets. Female Breast Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. 2015\u20132017."},{"key":"849_CR5","unstructured":"National Cancer Center Japan. https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/summary.html. (2017)."},{"key":"849_CR6","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98:1457\u201366.","journal-title":"Br J Cancer"},{"key":"849_CR7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"849_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.2007.55-a","volume":"299","author":"CB Begg","year":"2008","unstructured":"Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, et al. Variation of breast cancer risk among BRCA1\/2 carriers. JAMA. 2008;299:194\u2013201.","journal-title":"JAMA."},{"key":"849_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Coll\u00e9e MJ, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet. 2014;51:98\u2013107.","journal-title":"J Med Genet"},{"key":"849_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","volume":"24","author":"S Chen","year":"2006","unstructured":"Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006;24:863\u201371.","journal-title":"J Clin Oncol"},{"key":"849_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-155","volume":"8","author":"DG Evans","year":"2008","unstructured":"Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer. 2008;8:155.","journal-title":"BMC Cancer"},{"key":"849_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676\u201389.","journal-title":"Am J Hum Genet"},{"key":"849_CR13","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1073\/pnas.1415979111","volume":"111","author":"E Gabai-Kapara","year":"2014","unstructured":"Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci USA. 2014;111:14205\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"849_CR14","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA."},{"key":"849_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s10038-017-0355-1","volume":"63","author":"M Arai","year":"2018","unstructured":"Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, et al. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. J Hum Genet. 2018;63:447\u201357.","journal-title":"J Hum Genet"},{"key":"849_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF02586773","volume":"22","author":"HT Lynch","year":"1979","unstructured":"Lynch HT, Lynch PM. The cancer-family syndrome: a pragmatic basis for syndrome identification. Dis Colon Rectum. 1979;22:106\u201310.","journal-title":"Dis Colon Rectum"},{"key":"849_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF02053699","volume":"34","author":"HF Vasen","year":"1991","unstructured":"Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424\u20135.","journal-title":"Dis Colon Rectum"},{"key":"849_CR18","volume-title":"A clinical study of familial cancer in Japan","year":"1992","unstructured":"Nomizu T, Abe R, Tsuchiya A, Utsunomiya J, Watanabe F, Yamaki Y, editors. A clinical study of familial cancer in Japan. Berlin, Heidelberg: Springer Berlin Heidelberg; 1992."},{"key":"849_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF02966513","volume":"4","author":"T Nomizu","year":"1997","unstructured":"Nomizu T, Tsuchiya A, Kanno M, Katagata N, Watanabe F, Yamaki Y, et al. Clinicopathological features of hereditary breast cancer. Breast Cancer (Tokyo, Jpn). 1997;4:239\u201342.","journal-title":"Breast Cancer (Tokyo, Jpn)"},{"key":"849_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1158\/0008-5472.CAN-03-2970","volume":"64","author":"WD Foulkes","year":"2004","unstructured":"Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Begin LR, et al. The prognostic implication of the basal-like (cyclin E high\/p27 low\/p53+\/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res. 2004;64:830\u20135.","journal-title":"Cancer Res"},{"key":"849_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1053\/ctrv.2001.0233","volume":"27","author":"MO Nicoletto","year":"2001","unstructured":"Nicoletto MO, Donach M, De Nicolo A, Artioli G, Banna G, Monfardini S. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. Cancer Treat Rev. 2001;27:295\u2013304.","journal-title":"Cancer Treat Rev"},{"key":"849_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fphar.2018.00909","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Wu J, Zhang Z, Tang Y, Li X, Liu S, et al. Association between BRCA status and triple-negative breast cancer: a meta-analysis. Front Pharmacol. 2018;9:909.","journal-title":"Front Pharmacol"},{"key":"849_CR23","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/j.1349-7006.2008.00944.x","volume":"99","author":"K Sugano","year":"2008","unstructured":"Sugano K, Nakamura S, Ando J, Takayama S, Kamata H, Sekiguchi I, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast\/ovarian cancer. Cancer Sci. 2008;99:1967\u201376.","journal-title":"Cancer Sci"},{"key":"849_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480\u201390.","journal-title":"J Clin Oncol"},{"key":"849_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33:304\u201311.","journal-title":"J Clin Oncol"},{"key":"849_CR26","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115:2222\u201333.","journal-title":"Cancer."},{"key":"849_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, et al. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol. 2013;31:210\u20136.","journal-title":"J Clin Oncol"},{"key":"849_CR28","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3892\/ol.2014.1834","volume":"7","author":"G Palomba","year":"2014","unstructured":"Palomba G, Budroni M, Olmeo N, Atzori F, Ionta MT, Pisano M, et al. Triple-negative breast cancer frequency and type of BRCA mutation: clues from Sardinia. Oncol Lett. 2014;7:948\u201352.","journal-title":"Oncol Lett"},{"key":"849_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cge.12174","volume":"85","author":"P Ghadirian","year":"2014","unstructured":"Ghadirian P, Robidoux A, Nassif E, Martin G, Potvin C, Patocskai E, et al. Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal. Clin Genet. 2014;85:31\u20135.","journal-title":"Clin Genet"},{"key":"849_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121:25\u201333.","journal-title":"Cancer."},{"key":"849_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","volume":"151","author":"E Kang","year":"2015","unstructured":"Kang E, Seong MW, Park SK, Lee JW, Lee J, Kim LS, et al. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat. 2015;151:157\u201368.","journal-title":"Breast Cancer Res Treat"},{"key":"849_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, et al. Prevalence of BRCA1\/2 germline mutations in 21401 families with breast and ovarian cancer. J Med Genet. 2016;53:465\u201371.","journal-title":"J Med Genet"},{"key":"849_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2016;18:823\u201332.","journal-title":"Genet Med"},{"key":"849_CR34","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721\u201330.","journal-title":"Cancer."},{"key":"849_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmedgenet-2017-104947","volume":"55","author":"WX Wen","year":"2018","unstructured":"Wen WX, Allen J, Lai KN, Mariapun S, Hasan SN, Ng PS, et al. Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia. J Med Genet. 2018;55:97\u2013103.","journal-title":"J Med Genet"},{"key":"849_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018;9:4083.","journal-title":"Nat Commun"},{"key":"849_CR37","doi-asserted-by":"publisher","first-page":"e194428","DOI":"10.1001\/jamanetworkopen.2019.4428","volume":"2","author":"Z Kemp","year":"2019","unstructured":"Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2:e194428.","journal-title":"JAMA Netw Open"},{"key":"849_CR38","unstructured":"Center for Cancer Control and Information Services NCC. Cancer Statistics in Japan \u201817. 2017. https:\/\/ganjoho.jp\/data\/reg_stat\/statistics\/brochure\/2017\/cancer_statistics_2017.pdf."},{"key":"849_CR39","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Genetic\/familial high-risk assessment: breast and ovarian Version 1.2020. 2019."},{"key":"849_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","volume":"22","author":"AW Kurian","year":"2010","unstructured":"Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol. 2010;22:72\u20138.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"849_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/CLEP.S206949","volume":"11","author":"N Armstrong","year":"2019","unstructured":"Armstrong N, Ryder S, Forbes C, Ross J, Quek RG. A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol. 2019;11:543\u201361.","journal-title":"Clin Epidemiol"},{"key":"849_CR42","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol. 2016;34:1460\u20138.","journal-title":"J Clin Oncol"},{"key":"849_CR43","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","volume":"26","author":"DP Atchley","year":"2008","unstructured":"Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol. 2008;26:4282\u20138.","journal-title":"J Clin Oncol"},{"key":"849_CR44","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/modpathol.3800453","volume":"18","author":"E Honrado","year":"2005","unstructured":"Honrado E, Benitez J, Palacios J. The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol. 2005;18:1305\u201320.","journal-title":"Mod Pathol"},{"key":"849_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","volume":"16","author":"A Musolino","year":"2007","unstructured":"Musolino A, Bella MA, Bortesi B, Michiara M, Naldi N, Zanelli P, et al. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. Breast. 2007;16:280\u201392.","journal-title":"Breast."},{"key":"849_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncr.32540","volume":"126","author":"Y Song","year":"2020","unstructured":"Song Y, Barry WT, Seah DS, Tung NM, Garber JE, Lin NU. Patterns of recurrence and metastasis in BRCA1\/BRCA2-associated breast cancers. Cancer. 2020;126:271\u201380.","journal-title":"Cancer."},{"key":"849_CR47","doi-asserted-by":"publisher","first-page":"e0134408","DOI":"10.1371\/journal.pone.0134408","volume":"10","author":"ES Wong","year":"2015","unstructured":"Wong ES, Shekar S, Chan CH, Hong LZ, Poon SY, Silla T, et al. Predictive Factors for BRCA1 and BRCA2 genetic testing in an Asian clinic-based population. PLoS ONE. 2015;10:e0134408.","journal-title":"PLoS ONE"},{"key":"849_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4029-y","volume":"18","author":"C Engel","year":"2018","unstructured":"Engel C, Rhiem K, Hahnen E, Loibl S, Weber KE, Seiler S, et al. Prevalence of pathogenic BRCA1\/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history. BMC Cancer. 2018;18:265.","journal-title":"BMC Cancer"},{"key":"849_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377:523\u201333.","journal-title":"N Engl J Med"},{"key":"849_CR50","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329\u201333.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00849-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00849-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00849-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T19:05:29Z","timestamp":1709319929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00849-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["849"],"URL":"https:\/\/doi.org\/10.1038\/s10038-020-00849-y","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"13 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}